EFR3B
Protein EFR3 homolog B
Also known as: EFR3B_HUMAN, FLJ37871, KIAA0953
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2G0
- Gene
- EFR3B
- Ensembl
- ENSG00000084710
- Chromosome
- 2
- Canonical length
- 817 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Actin filaments,Cytosol
OverviewNCBI Gene
Involved in phosphatidylinositol phosphate biosynthetic process and protein localization to plasma membrane. Located in actin cytoskeleton; cytosol; and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
817 residues, UniProt reviewed canonical sequence.
>Q9Y2G0|EFR3B
1 MYGVCGCCGA LRPRYKRLVD NIFPEDPEDG LVKTNMEKLT FYALSAPEKL DRIGAYLSER
61 LIRDVGRHRY GYVCIAMEAL DQLLMACHCQ SINLFVESFL KMVAKLLESE KPNLQILGTN
121 SFVKFANIEE DTPSYHRSYD FFVSRFSEMC HSSHDDLEIK TKIRMSGIKG LQGVVRKTVN
181 DELQANIWDP QHMDKIVPSL LFNLQHVEEA ESRSPSPLQA PEKEKESPAE LAERCLRELL
241 GRAAFGNIKN AIKPVLIHLD NHSLWEPKVF AIRCFKIIMY SIQPQHSHLV IQQLLGHLDA
301 NSRSAATVRA GIVEVLSEAA VIAATGSVGP TVLEMFNTLL RQLRLSIDYA LTGSYDGAVS
361 LGTKIIKEHE ERMFQEAVIK TVGSFASTLP TYQRSEVILF IMSKVPRPSL HQAVDTGRTG
421 ENRNRLTQIM LLKSLLQVST GFQCNNMMSA LPSNFLDRLL STALMEDAEI RLFVLEILIS
481 FIDRHGNRHK FSTISTLSDI SVLKLKVDKC SRQDTVFMKK HSQQLYRHIY LSCKEETNVQ
541 KHYEALYGLL ALISIELANE EVVVDLIRLV LAVQDVAQVN EENLPVYNRC ALYALGAAYL
601 NLISQLTTVP AFCQHIHEVI ETRKKEAPYM LPEDVFVERP RLSQNLDGVV IELLFRQSKI
661 SEVLGGSGYN SDRLCLPYIP QLTDEDRLSK RRSIGETISL QVEVESRNSP EKEERVPAEE
721 ITYETLKKAI VDSVAVEEQE RERRRQVVEK FQKAPFEEIA AHCGARASLL QSKLNQIFEI
781 TIRPPPSPSG TITAAYGQPQ NHSIPVYEMK FPDLCVYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EFR3B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 33 nTPM
- cerebellum: 26 nTPM
- cerebral cortex: 24 nTPM
- hippocampal formation: 22 nTPM
- amygdala: 19 nTPM
- skeletal muscle: 19 nTPM
Single-cell type
- retinal pigment epithelial cells: 537 nCPM
- retinal ganglion cells: 240 nCPM
- astrocytes: 208 nCPM
- brain inhibitory neurons: 164 nCPM
- brain excitatory neurons: 135 nCPM
- lactotrophs: 125 nCPM
Immune cell
- basophil: 1.3 nTPM
- neutrophil: 0.4 nTPM
- eosinophil: 0.3 nTPM
- gdT-cell: 0.2 nTPM
- naive B-cell: 0.2 nTPM
- NK-cell: 0.2 nTPM
Brain region
- basal ganglia: 154 nTPM
- hippocampal formation: 153 nTPM
- pons: 143 nTPM
- medulla oblongata: 113 nTPM
- cerebral cortex: 105 nTPM
- thalamus: 103 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 4.26
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- phosphatidylinositol phosphate biosynthetic process
- protein localization to plasma membrane
- social behavior
- transmission of nerve impulse
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EFR3B as an antibody target. Whether an autoantibody or antibody against EFR3B could matter depends on whether native EFR3B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EFR3B is annotated at the cell surface, where native EFR3B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EFR3B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...